Aptinyx Inc reported $-19379000 in EBIT for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -113016000 68.36M
Acorda Therapeutics ACOR:US $ -13503000 3.34M
Biogen BIIB:US $ 531.5M 11.7M
Cara Therapeutics CARA:US $ -27911000 5.61M
Daiichi Sankyo 4568:JP -50747000000 89.78B
Eli Lilly And LLY:US $ 2569.9M 171.6M
Halozyme Therapeutics HALO:US $ 75.67M 19.14M
Intra Cellular Therapies ITCI:US $ -72662000 13.34M
IONIS PHARMACEUT IONS:US $ -57504000 278.11M
Marinus Pharmaceuticals MRNS:US -16711000 10.4M
Neurocrine Biosciences NBIX:US $ 3.1M 60.9M
Novartis NOVN:VX 3.15B 266M
Ultragenyx Pharmaceutical RARE:US $ -136632000 34.07M
Vertex Pharmaceuticals VRTX:US $ 1033.4M 157.68M